Healthy Living Colorado
- NAD IV Therapy
- Vitamin IV Therapy
- Ozone Therapy
- IV Therapy
- IV Hydration
Greenwood Village, CO
Greenwood Village sits at the center of the Denver Tech Center (DTC) corridor and hosts an unusually dense IV therapy scene for its small resident population, driven almost entirely by corporate daytime traffic. Clinics cluster along East Belleview, near Fiddler's Green, and within the DTC office cluster itself, with overflow volume from Centennial, Englewood, and Cherry Hills. HealthONE's Sky Ridge, Swedish Medical, and the UCHealth network anchor the clinical ecosystem supplying medical directors. Colorado is a full-practice state for nurse practitioners, so many Greenwood Village IV clinics are NP-led alongside physician-director models. Altitude demand is real (roughly 5,700 feet), and DTC corporate wellness programs at Charles Schwab, CoreSite, Western Union, and surrounding employers drive executive NAD+, B12, and vitamin C volume. Mobile IV services deliver to DTC offices during the workday and to Cherry Hills and Greenwood Village residences in the evening.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Colorado medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.